I'm assuming this is an (in)direct take on that whole thing:
I'm assuming this is an (in)direct take on that whole thing:
The research sounds similar to a well-known approach promoted in the past for testing a single drop of blood, but there are important differences: While the earlier approach was based on replicating existing diagnostic tests, multi-omic microsampling uses a different type of data analysis based on a technology called mass spectrometry, which sorts molecules based on their mass and electronic charge. In addition, the data analysis is performed in a lab, not in a portable box.
Although this is a twist on traditional mass spectometry, they're still relatively small, dare say a small portable box form. I wouldn't be surprised in a revival of Holmes' business model only...
multi-omic microsampling uses a different type of data analysis based on a technology called mass spectrometry
I'm assuming this is an (in)direct take on that whole thing:
Although this is a twist on traditional mass spectometry, they're still relatively small, dare say a small portable box form.
I wouldn't be surprised in a revival of Holmes' business model only under a more sanctioned developer like Medtyronic, J&J or, Siemens.